DR. JOHN J. ALAM, M.D.
Osteopathic Medicine at Waverly St, Cambridge, MA
License number
Massachusetts 59328
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
130 Waverly St, Cambridge, MA 02139
Phone
(617) 444-6100
Personal information
See more information about JOHN J. ALAM at radaris.comName
Address
Phone
11 Channing St, Cambridge, MA 02138
9 Prospect St, Winchester, MA 01890
11 Channing St, Cambridge, MA 02138
43 Gurnet Rd, Duxbury, MA 02332
9 Prospect St, Winchester, MA 01890
Professional information
John Jahangir Alam, Cambridge MA
Specialties:
Internist
Address:
130 Waverly St, Cambridge, MA 02139
Education:
Northwestern University, Feinberg School of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Residency - Internal Medicine
Brigham & Women's Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. John J Alam, Cambridge MA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
11 Channing St, Cambridge 02138
(617) 669-8426 (Phone)
(617) 669-8426 (Phone)
Certifications:
Internal Medicine, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1986
Brigham and Womens Hospital
Northwestern Center Feinberg School of Medicine
Graduated: 1986
Brigham and Womens Hospital
Head, Tsu Aging At Sanofi
Position:
Head, TSU Aging at Sanofi, Board of Overseers at WGBH
Location:
Paris Area, France
Industry:
Pharmaceuticals
Work:
Sanofi
- Chilly-Mazarin/Paris, France since Jan 2011
-
Head, TSU Aging
WGBH
since 2006
-
Board of Overseers
Vertex Pharmaceuticals
- Cambridge,MA 1997 - 2008
-
Various
Biogen Idec
- Cambridge, MA 1991 - 1997
-
Various
Education:
Northwestern University - The Feinberg School of Medicine 1982 - 1986
Doctor of Medicine (MD) Massachusetts Institute of Technology 1978 - 1982
SB, Chemical Engineering
Doctor of Medicine (MD) Massachusetts Institute of Technology 1978 - 1982
SB, Chemical Engineering
Combination Therapy For Hcv Infection
US Patent:
2005011, May 26, 2005
Filed:
Oct 12, 2004
Appl. No.:
10/964243
Inventors:
Ene Ette - Framingham MA, US
John Alam - Cambridge MA, US
Robert Kauffman - Chestnut Hill MA, US
John Alam - Cambridge MA, US
Robert Kauffman - Chestnut Hill MA, US
International Classification:
A61K038/21, A61K038/05, A61K031/7056
US Classification:
424085400, 514043000, 514018000
Abstract:
The present invention relates to therapeutic combinations comprising VX-497, ribavirin, and interferon. The present invention also relates to methods using the therapeutic combinations of the present invention for treating HCV infection or alleviating one or more symptoms thereof in a patient. The present invention also provides kits comprising the combinations of the present invention.
Hcv Combination Therapies Comprising Pegylated Interferon, Ribavirin And Telaprevir
US Patent:
2012003, Feb 16, 2012
Filed:
Aug 11, 2011
Appl. No.:
13/207773
Inventors:
Lindsay McNair - Allston MA, US
Robert S. Kauffman - Chestnut Hill MA, US
John J. Alam - Cambridge MA, US
Ramon Polo - Basking Ridge NJ, US
Gaston Rafael Picchio - Flemington NJ, US
Maria Gloria Beumont - Issy Les Moulineaux, FR
Robert S. Kauffman - Chestnut Hill MA, US
John J. Alam - Cambridge MA, US
Ramon Polo - Basking Ridge NJ, US
Gaston Rafael Picchio - Flemington NJ, US
Maria Gloria Beumont - Issy Les Moulineaux, FR
Assignee:
Janssen Pharmaceutica NV - Beerse
Vertex Pharmaceuticals Incorporated - Cambridge MA
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 38/21, A61P 31/14
US Classification:
424 857, 424 854
Abstract:
The invention relates to combination therapies for the treatment of hepatitis C virus with telaprevir and pegylated interferon alfa-2a with or without ribavirin. The invention relates to the treatment of patients with bridging fibrosis infected with HCV using the combination therapy.
Dose Forms Comprising Vx-950 And Their Dosage Regimen
US Patent:
2010018, Jul 29, 2010
Filed:
Nov 20, 2009
Appl. No.:
12/592225
Inventors:
Lindsay McNair - Allston MA, US
Robert S. Kauffman - Chestnut Hill MA, US
John J. Alam - Cambridge MA, US
Bambang S. Adiwijaya - Belmont MA, US
Varun Garg - Framingham MA, US
Ann D. Kwong - Cambridge MA, US
Tara L. Kieffer - Brookline MA, US
Robert S. Kauffman - Chestnut Hill MA, US
John J. Alam - Cambridge MA, US
Bambang S. Adiwijaya - Belmont MA, US
Varun Garg - Framingham MA, US
Ann D. Kwong - Cambridge MA, US
Tara L. Kieffer - Brookline MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
International Classification:
A61K 38/21
US Classification:
424 857, 424 854
Abstract:
The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.
Methods For Monitoring Il-18
US Patent:
2005020, Sep 22, 2005
Filed:
Nov 10, 2004
Appl. No.:
10/985641
Inventors:
Amit Roy - Plainsboro NJ, US
Matthew Harding - Acton MA, US
John Alam - Cambridge MA, US
John Randle - Brookline MA, US
Matthew Harding - Acton MA, US
John Alam - Cambridge MA, US
John Randle - Brookline MA, US
International Classification:
A61K038/04, G01N033/00
US Classification:
514019000, 436086000
Abstract:
This invention relates to methods for monitoring IL-18.
Compositions And Methods For Treating Alzheimer's Disease
US Patent:
2012028, Nov 15, 2012
Filed:
May 9, 2012
Appl. No.:
13/467519
Inventors:
John Jahangir Alam - Cambridge MA, US
Assignee:
EIP PHARMA, LLC - Cambridge MA
International Classification:
A61K 31/519, A61P 25/28
US Classification:
514248
Abstract:
The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
Methods For Monitoring Il-18
US Patent:
2009021, Aug 27, 2009
Filed:
Apr 24, 2009
Appl. No.:
12/386933
Inventors:
Amit Roy - Plainsboro NJ, US
Matthew W. Harding - Acton MA, US
John Alam - Cambridge MA, US
John Randle - Brookline MA, US
Matthew W. Harding - Acton MA, US
John Alam - Cambridge MA, US
John Randle - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 31/40, G01N 33/53, A61P 43/00
US Classification:
514423, 435 71
Abstract:
This invention relates to methods for monitoring IL-18.
Dose Forms
US Patent:
2006010, May 18, 2006
Filed:
Oct 31, 2005
Appl. No.:
11/264746
Inventors:
Hui-May Chu - Natick MA, US
Ene Ette - Framingham MA, US
Lindsay McNair - Allston MA, US
John Alam - Cambridge MA, US
Ene Ette - Framingham MA, US
Lindsay McNair - Allston MA, US
John Alam - Cambridge MA, US
International Classification:
A61K 31/70, A61K 39/12, A01N 43/04
US Classification:
514044000, 424204100
Abstract:
The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.